April 12-13: Q1 Productions | Partnerships in Personalized Medicine Conference Recognizing the Opportunity in Personalized Medicine Through Partnerships in the Development and Commercialization of Companion Diagnostics.
This conference program will provide a platform for both diagnostic and therapeutic companies to come together to discuss the challenges and inherent opportunities that exist in partnerships established to enhance personalized medicine and companion diagnostics. Through case studies that highlight the successes in development, regulatory hurdles and commercialization of these companion tests, to round-table discussions that delve into specific therapeutic areas such as cancer, heart disease and diabetes. The conference will lead off with a Keynote presentation from Chris Meda, The CEO of Arcxis Biotechnologies, entitled The Role of Personalized Medicine in the Future of Diagnostics. Additional presenters to include: Bill Pignato, The Global Regulatory Head at Novartis, & Paul Beresford M.D, the Vice President of Business Development & Strategic Marketing at Biodesix. And many more…
BayBio members receive a 10% percent discount from the standard registration fee. Please mention promo code CODE at time of registration to receive the reduced rate. The discount can not be used with other promotional offers. In San Mateo. Detailed Information http://q1productions.com/eventPages/event_LSCONF-2020.php
